Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2010 | 44.05% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2011 | -1.22% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2012 | -0.87% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2013 | 20.11% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2014 | 26.11% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2015 | 33.71% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2016 | -68.4% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2017 | 23.33% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2018 | -18.98% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2019 | -63.84% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2020 | -8.23% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2021 | 2.79% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2022 | -58.88% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2023 | 196.1% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2024 | 29.62% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2025 | 58.89% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2026 | -5.69% |
